Previous Close | 16.19 |
Open | 16.16 |
Bid | 15.80 x 800 |
Ask | 16.01 x 2200 |
Day's Range | 15.73 - 16.79 |
52 Week Range | 4.81 - 19.43 |
Volume | 1,130,239 |
Avg. Volume | 2,348,391 |
Market Cap | 2.228B |
Beta (5Y Monthly) | 1.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.59 |
Earnings Date | Feb 26, 2021 - Mar 02, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 20.70 |
Today is shaping up negative for Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) shareholders, with the analysts delivering...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last day of employment will be February 1, 2021.
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th at 5:20pm EST.